Business Daily Media

Men's Weekly

.

Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

  • Written by PR Newswire
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication –

– Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 –

NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc....

More Articles ...

  1. Quantifi Photonics raises $15M in Series C funding round led by Intel Capital
  2. Binance Australia Derivatives successfully launches crypto CFDs under an Australian Financial Services Licence
  3. The Fifth CIIE brings global products from coastal states of the South Pacific to China
  4. Announcing the Release of The Disruptors, the First Comprehensive Documentary Film on ADHD Award-Winning, Star-Studded Documentary Available in New Zealand on Apple TV/iTunes, Google Play & YouTube
  5. Hong Leong Financial Group Named Malaysia's Best Managed Bank and Financial Holding Group 2022 by The Asian Banker
  6. Former Bank of England Senior Advisor to Spearhead MetaVerse Green Exchange's Climate Action in Southeast Asia
  7. Telix Reports Second Quarter 2022 Financial Results
  8. Airwallex launches Online Payments App on Shopify
  9. PAX.WORLD: 'METAVERSE OF THE YEAR' LAUNCHES FIRST PUBLIC LAND SALE
  10. Former Australian Prime Minister and Former Alcoa COO Join GlassPoint's Advisory Board

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Australian Businesses Still Stuck in the AI Hype Cycle

Data Governance Failures, ROI Gaps and Unclear Strategy Slowing Progress Despite artificial intelligence (AI) dominating headlines and boardroom ag...

How to ensure your manufacturing business survives international tariff turmoil

Optimising your operations in FY2026 will help you combat the challenges of a volatile trading environment. Up, down, in out…Since the commence...

Why Apptio is Enhancing Visibility into AI and Hybrid Cloud

AI investments have become a strategic priority for business with the mindset that if you're not using AI, you're falling behind. But according to...

Beyond borders: Building a scalable strategy for international hiring

For many Australian businesses, growth increasingly depends on thinking beyond local borders.  As wage pressures rise, and specialised talent pool...

Sell by LayBy